The use of combination treatments in early phase oncology trials is growing. The objective of these trials is to search for the maximum tolerated dose combination from a pre-defined set. However, cases in which the initial set of combinations does not contain one close to the target toxicity level pose a significant challenge. There is uncertainty around how to handle these situations...
Fast-track procedures play an important role in the registration of health products, such as registration processes for digital health applications. These procedures offer the potential for patients to access innovative products earlier. The procedures involve two registration steps. Applicants can first apply for conditional registration. A successful conditional registration provides a...
Graph-based multiple testing procedures provide an intuitive way to define closed testing strategies that control the family-wise error rate (FWER) in fixed sample settings [1]. They have been extended to adaptive trial designs based on the (partial) conditional error rate (CER) method [2]. These procedures control the FWER in two-stage designs where the trial is adapted after an interim...
We propose a frequentist, adaptive trial design to investigate the safety and efficacy of three dose levels compared to placebo for the treatment of worm infections. As the safety of the highest dose is not yet established, the study starts with the two lower doses and the control arm. Based on safety and efficacy endpoints observed in an interim analysis, it is decided to either continue...
Background: We consider clinical trials in which the experimental treatment may have heterogeneous effects across pre-specified patient subpopulations. In such settings, two-stage adaptive enrichment designs allow the enrolled population to be modified at an interim analysis. In stage 1, patients are enrolled from the full population, and based on interim data and preplanned selection rules,...
